SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-064850
Filing Date
2017-10-31
Accepted
2017-10-31 10:28:59
Documents
11
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 20-F a17-24540_120f.htm 20-F 3379186
2 EX-12.01 a17-24540_1ex12d01.htm EX-12.01 12114
3 EX-12.02 a17-24540_1ex12d02.htm EX-12.02 12426
4 EX-13.01 a17-24540_1ex13d01.htm EX-13.01 6352
5 EX-13.02 a17-24540_1ex13d02.htm EX-13.02 6399
6 EX-23.01 a17-24540_1ex23d01.htm EX-23.01 3263
7 GRAPHIC g245401gei001.jpg GRAPHIC 16801
8 GRAPHIC g245401bki001.jpg GRAPHIC 16857
9 GRAPHIC g245401fni001.jpg GRAPHIC 2233
10 GRAPHIC g245401lei001.jpg GRAPHIC 1908
11 GRAPHIC g245401bei001.gif GRAPHIC 43123
  Complete submission text file 0001104659-17-064850.txt   3532863
Mailing Address 60-66 HANOVER STREET FITZROY, VICTORIA C3 3065
Business Address 60-66 HANOVER STREET FITZROY, VICTORIA C3 3065 011613-9415-1135
GENETIC TECHNOLOGIES LTD (Filer) CIK: 0001166272 (see all company filings)

IRS No.: 000000000
Type: 20-F | Act: 34 | File No.: 000-51504 | Film No.: 171164421
SIC: 2836 Biological Products, (No Diagnostic Substances)